DaRT treatment before surgery for oral cavity squamous cancer
Part of Cancer clinical trials.
This trial studies DaRT, a treatment given before surgery, to improve outcomes for certain oral cavity squamous cell cancers that can be fully removed. You would be carefully selected using scans and tests to make sure the cancer is in the right place and you can safely receive the treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed oral cavity squamous cell cancer diagnosis and have not had any prior cancer treatment for it
- Your tumor is operable (can be removed with standard curative treatments) and fits specific size/extent limits
- Your cancer location can be fully covered by the DaRT seeds, including safety margins around the tumor
- You can get recommended scans (PET-CT and MRI, as planned by the study team) within about 2 weeks before joining
- Your health tests are adequate (blood counts, kidney function, and blood clotting are within required ranges)
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control during the study and for 6 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a targeted internal radiation treatment (DaRT) combined with pembrolizumab (an immune therapy) can shrink recurrent or metastatic head and neck squamous cell cancer that cannot be fully removed with surgery. It may help by making cancer more visible to the immune system while delivering localized radiation to a tumor area.
This trial tests a special radiation device (DaRT) placed directly into skin cancer tumors. It is designed for patients with weakened immune systems (immunocompromised) who have a single skin cancer lesion on the skin (not spread elsewhere).
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
This trial tests a targeted radiation device (DaRT seeds) to treat certain cancers on the skin, in the mouth, or in superficial soft tissue. It may help when standard treatment (like surgery or regular radiation/chemo) hasn’t worked, isn’t safe, or isn’t wanted.
This trial studies a radiation-emitting device (DaRT) to treat certain cancers on the skin, in the mouth, or in superficial soft tissues. You may qualify if you have a confirmed malignant tumor, enough body strength for treatment, and blood tests and pregnancy status that meet safety limits.
This study tests a radiation-emitting device (called DaRT) for treating cancer tumors. It may help shrink or control malignant tumors and researchers will check safety and response to the treatment.
Hear when a new Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.